NF-κB and ICAM-1 are essential to elicit ischemia-induced blood–brain barrier damage [52]; thus, the CaCCs inhibition could have a beneficial effect in the treatment of ischemic stroke. This evidence concerns the gene ICAM1 and ischemic stroke.